(Boursier.com) — Carmat announces the launch of a fundraising of approximately 30 million euros via the issue of new shares at a fixed price of 10.50 Euros per share aimed at specialized and strategic investors as defined below and retail investors through the PrimaryBid platform.
The company plans to use the proceeds from the fundraising to support the development of its activities and in particular, the ramp-up of its production, the recovery and growth of Aeson sales and the launch of the EFICAS clinical study. in France.
©2022 Boursier.com